ABCL – abcellera biologics inc. - common shares (US:NASDAQ)
Stock Stats
News
AbCellera to Report First Quarter 2025 Financial Results on May 8, 2025
AbCellera Announces Presentation of In Vivo Data on PSMA x CD3 T-Cell Engagers at AACR 2025
AbCellera Biologics Inc. (NASDAQ: ABCL) had its "hold" rating re-affirmed by analysts at Benchmark Co..
AbCellera Biologics Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]
AbCellera Biologics (ABCL) Q4 2024 Earnings Call Transcript [Yahoo! Finance]
Form 4 AbCellera Biologics Inc. For: Mar 11 Filed by: Thermopylae Holdings Ltd.
Form 4 AbCellera Biologics Inc. For: Mar 10 Filed by: Montalbano John S.
Form 4 AbCellera Biologics Inc. For: Mar 06 Filed by: Montalbano John S.
Form S-3ASR AbCellera Biologics Inc.
Form S-8 AbCellera Biologics Inc.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.